ORKTS logo
  • Research & Funding
  • Intellectual Property Licensing
  • Knowledge Transfer Initiatives
  • Contract Services
Chinese University of Hong Kong logo
Slideshow 01
Intellectual Property Licensing
  • Home
  • Intellectual Property Licensing
Available Technologies
  • Overview
  • Featured Inventions
  • See All Inventions
  • Commercialize Your Research
  • Patent Your Invention
  • Download Forms

Search Results - kin+wah+kenneth+to

3 Results Sort By:
A Novel Bioactive and Digradable Magnesium-based Screw Construct for Fracture Fixation
[Licensing negotiation in progress][Invitation for Expression of Interest- Deadline: 6 January 2019]We are inviting expressions of interest (EoI) for commercializing “A Novel Bioactive and Degradable Magnesium-based Screw Construct for Fracture Fixation” technology. The innovation is developed by Professor QIN Ling, of Orthopaedics and...
Inventor(s): Ling QIN, Li Tian, To Ngai, Chi Wu, Kwok Sui Leung
Keywords(s):  
Category(s): Medical Devices
System and method for patient privacy protection in medical images
[Licensing negotiation in progress] [Invitation for Expression of Interest- Deadline: 5 March 2021] We are inviting expressions of interest (EoI) for commercializing “System and Method for Patient Privacy Protection in Medical Images” technology. The innovation is developed by Professor Weitian CHEN, Professor of the Department of Imaging...
Inventor(s): Weitian CHEN, Ke GAN
Keywords(s):  
Category(s): Medical Imaging
Compounds Targeting on ABC Transporter-mediated Multidrug Resistance from TCM
Invention Reference: 11/MED/424 The ability of cancer cells to acquire resistance to multiple drugs, termed multidrug resistance (MDR), is often mediated by overexpression of ATP-binding cassette (ABC) transporters that remove substrates out of the cell against a concentration gradient. Among 48 human ABC transporters discovered, three, namely P-glycoprotein...
Inventor(s): Ge Lin, Kin Wah Kenneth To, Stella Chai, Yang Ye, Liang Ma, Chun Ping Tang
Keywords(s):  
Category(s): Therapeutics